Z:\Agnes\Councils\Scientific_Council\SC_ Membership\Biosketches\2014\BiosketchSC2014_Rev080114.docx Page 1 of 24

Z:\Agnes\Councils\Scientific_Council\SC_
Membership\Biosketches\2014\BiosketchSC2014_Rev080114.docx
Page 1 of 24
AUSTRALIA (elected in 2012 – mandate expires in 2016)
James F. BISHOP, AO – MD, MMed, MB BS, FRACP, FRCPA
AUSTRALIA
ADDRESS: Executive Director
Victorian Comprehensive Cancer Centre
766 Elizabeth Street
PO Box 2148
Royal Melbourne Hospital, VIC 3050, Australia
Tel.: [phone]
E-mail: [email protected]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1972
1979
1979
1989
1999
University of Melbourne
Royal Australasian College of Physicians
Royal College of Pathologists of Australia
University of Melbourne
University of Melbourne
MBBS
FRACP
FRCPA
M.D.
MMed
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
2011 – present
2011 – present
2009 – 2011
2011
2011
2003 – 2011
2003 – 2009
2003 – 2009
1995 – 2003
1995 – 2003
1995 – present
1990 – 1995
Professor of Cancer Medicine, The University of Melbourne
Executive Director, The Victorian Comprehensive Cancer Centre
Chief Medical Officer, Department of Health and Ageing, Australian
Government
National Director of Human Quarantine, Australian Government
Director, Office of Health Protection, Department of Health and Ageing,
Canberra
Honorary Medical Oncologist, Royal Prince Alfred Hospital, Sydney
Chief Cancer Officer for New South Wales
CEO, Cancer Institute NSW
Director, Sydney Cancer Centre, Royal Prince Alfred and Concord
Hospitals
Clinical Director, Cancer Services, Central Sydney Area Health Service
Professor of Medicine, The University of Sydney
Director, Division of Haematology
and Medical Oncology, Peter
MacCallum Cancer Institute, Melbourne
RESEARCH INTERESTS
Cancer chemotherapy; clinical trials; cancer epidemiology; cancer health services and
economics; health policy.

Z:\Agnes\Councils\Scientific_Council\SC_
Membership\Biosketches\2014\BiosketchSC2014_Rev080114.docx
Page 2 of 24
AUSTRIA (elected in 2013 – mandate expires in 2017)
Lukas A. HUBER, M.D.
AUSTRIA
ADDRESS: Director
Biocenter and Cell Biology Division
Medical University Innsbruck
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1989 University of Innsbruck, Austria M.D.
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
1990–1993
1993–1995
1995
1996–2002
2002–2004
Since 2005
2007–2008
Since 2009
Postdoctoral scientist, European Molecular Biology Laboratory (EMBL),
Heidelberg, Germany
Maître Assistant, Biochemistry Department, Geneva University,
Switzerland
General and Experimental Pathology, University of Innsbruck, Medical
School
Group Leader, Institute of Molecular Pathology, IMP, Vienna, Austria
Professor and Head, Histology and Molecular Cell Biology, Innsbruck
Medical University
Director and Head of the Biocenter, Medical University Innsbruck and
Director, Division of Cell Biology
Co-Director, Integrated Research and Therapy Center (IFTZ), Innsbruck
CSO, Center for Personalized Medicine, ONCOTYROL, Innsbruck
RESEARCH INTERESTS
Molecular cell biology, cell signalling and translational cancer research.

Z:\Agnes\Councils\Scientific_Council\SC_
Membership\Biosketches\2014\BiosketchSC2014_Rev080114.docx
Page 3 of 24
BELGIUM (elected in 2012 – mandate expires in 2016)
Christos SOTIRIOU, MD, Ph.D.
BELGIUM
ADDRESS: Institut Jules Bordet - BCTL
Rue Herger-Bordet, 1
1000 Brussels
Tel.: [phone]
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1993
1999
2004
Université Libre de Bruxelles (ULB), Brussels
Université Libre de Bruxelles (ULB), Brussels
Université Libre de Bruxelles (ULB), Brussels
M.D., Medicine and
Surgery
Postgraduate diploma in
Internal Medicine /
Medical Oncology
Ph.D. in Genomics
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
03/2010–present
From 10/2013
10/2005–09/2013
10/2005–present
10/2001–09/2005
10/1999–09/2001
10/1997–09/1999
10/1996–09/1997
10/1994–09/1996
10/1993–09/1994
Head of the Breast Cancer Translational Research Laboratory JC Heuson,
(BCTL) Faculty of Medicine, Université Libre de Bruxelles (ULB),
Brussels, Belgium.
“Maître de Recherche” FNRS (National Foundation for Scientific
Research) (Tenured position).
“Chercheur qualifié” FNRS (National Foundation for Scientific Research)
(Tenured position).
Associate Professor, Medical Oncology Unit, Jules Bordet Institute,
Université Libre de Bruxelles (ULB).
Assistant Professor, Medical Oncology Unit, Jules Bordet Institute,
Université Libre de Bruxelles (ULB).
Research Fellow, National Institutes of Health, National Cancer Institute,
Division of Clinical Sciences, Microarray facility, Bethesda, MD, USA.
Research fellow of the National Foundation for Scientific Research,
Department of Oncology, and Laboratory of Endocrinology, Bone
Metabolism and Breast Oncology, Jules Bordet Institute, Université
Libre de Bruxelles (ULB).
Postgraduate in Internal Medicine, Department of Oncology, Jules Bordet
Institute, Université Libre de Bruxelles (ULB).
Postgraduate in Internal Medicine, Department of Internal Medicine,
Etterbeek-Ixelles Center Hospital, Université Libre de Bruxelles (ULB).
Postgraduate in Internal Medicine, Department of Internal Medicine and
Oncology, Jules Bordet Institute, Université Libre de Bruxelles (ULB).
RESEARCH INTERESTS
Translational cancer research; breast cancer; clinical cancer biomarkers.

Z:\Agnes\Councils\Scientific_Council\SC_
Membership\Biosketches\2014\BiosketchSC2014_Rev080114.docx
Page 4 of 24
BRAZIL (elected in 2013 – mandate expires in 2017)
Luis Felipe Ribeiro PINTO, Ph.D.
BRAZIL
ADDRESS: Head of Molecular Carcinogenesis Program
Head of Education
Brazilian National Cancer Institute (INCA)
Rio de Janeiro
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1989
1994
Federal University, Rio de Janeiro
University College London, UK
Degree in Pharmacy
Ph.D. (Biochemistry and
Molecular Biology)
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
1996–
2003–2007
2007–
2012–
2012–
Reader, Biochemistry Departement, State University, Rio de Janeiro
(UERJ)
Head of Post-Graduation in Biology (UERJ)
Head of Post-Graduation in Oncology, Brazilian National Cancer Institute
(INCA)
Head of Education (INCA)
Head of Molecular Carcinogenesis Program (INCA)
RESEARCH INTERESTS
Mechanisms of carcinogenesis; molecular epidemiology; epigenetics and somatic mutations in
relation to etiological factors; developing biomarkers of early detection or targeted therapies
in upper aerodigestive tract tumours.

Z:\Agnes\Councils\Scientific_Council\SC_
Membership\Biosketches\2014\BiosketchSC2014_Rev080114.docx
Page 5 of 24
CANADA (elected in 2013 – mandate expires in 2017)
John J. SPINELLI, B.Sc., M.Sc., Ph.D.
CANADA
ADDRESS: Cancer Control Research
British Columbia Cancer Agency, Vancouver
E-mail: [e-mail]
EDUCATION
YEAR
INSTITUTION
QUALIFICATION
1979
1981
1994
Simon Fraser University
Simon Fraser University
Simon Fraser University
B.Sc. (Mathematics & Psychology)
M.Sc. Mathematics (Statistics)
Ph.D. Mathematics (Statistics)
PRINCIPAL POSITIONS HELD
YEAR
POSITION AND PLACE OF EMPLOYMENT
1995–1999
1995–2000
1999–2004
2000–2005
2005–2009
1999–current
2004–current
2006–current
2009–current
2009–current
2011–current
Faculty Biostatistician, St Paul’s Hospital, Centre for Health Evaluation &
Outcome Sciences
Assistant Professor, UBC, Department of Health Care and Epidemiology
Senior Scientist, BCCA, Cancer Control Research Program
Associate Professor, UBC, Department of Health Care and Epidemiology
Professor, UBC, Department of Health Care and Epidemiology
Adjunct Professor, Simon Fraser University, Department of Statistics and
Actuarial Science
Distinguished Scientist, BCCA, Cancer Control Research Program
Associate Member, UBC, Department of Statistics
Professor, UBC, School of Population and Public Health
Co-lead, Epidemiology & Biostatistics Theme, UBC, School of Population
and Public Health
Head, BCCA, Cancer Control Research Program
RESEARCH INTERESTS
Biostatistical and epidemiological methods; genetic and environmental risks for cancer,
particularly lymphoproliferative malignancies and breast cancer.